Compare, Analyse GSK Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs ACTAVIS (US) - Comparison Results

GSK PHARMA     Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   ACTAVIS
EQUITY SHARE DATA
    GSK PHARMA
Mar-19
ACTAVIS
Dec-18
GSK PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs3,59514,220-   
Low Rs1,2539,539-   
Sales per share (Unadj.) Rs184.73,488.2-  
Earnings per share (Unadj.) Rs26.3-1,123.6-  
Cash flow per share (Unadj.) Rs29.2367.6-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs126.314,387.3-  
Shares outstanding (eoy) m169.40332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x13.13.4 385.4%   
Avg P/E ratio x92.2-10.6 -871.9%  
P/CF ratio (eoy) x83.132.3 257.2%  
Price / Book Value ratio x19.20.8 2,324.0%  
Dividend payout %76.10-   
Avg Mkt Cap Rs m410,6263,951,174 10.4%   
No. of employees `0005.016.9 29.3%   
Total wages/salary Rs m5,3720-   
Avg. sales/employee Rs Th6,306.768,650.1 9.2%   
Avg. wages/employee Rs Th1,083.10-   
Avg. net profit/employee Rs Th898.0-22,112.2 -4.1%   
INCOME DATA
Net Sales Rs m31,2811,160,187 2.7%  
Other income Rs m1,02322,187 4.6%   
Total revenues Rs m32,3041,182,373 2.7%   
Gross profit Rs m6,00930,403 19.8%  
Depreciation Rs m486495,955 0.1%   
Interest Rs m666,949 0.0%   
Profit before tax Rs m6,540-510,315 -1.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m287130,151 0.2%   
Tax Rs m2,373-6,467 -36.7%   
Profit after tax Rs m4,454-373,697 -1.2%  
Gross profit margin %19.22.6 733.0%  
Effective tax rate %36.31.3 2,863.2%   
Net profit margin %14.2-32.2 -44.2%  
BALANCE SHEET DATA
Current assets Rs m20,061475,848 4.2%   
Current liabilities Rs m14,543420,951 3.5%   
Net working cap to sales %17.64.7 372.8%  
Current ratio x1.41.1 122.0%  
Inventory Days Days5720 289.9%  
Debtors Days Days1466 21.2%  
Net fixed assets Rs m14,343131,327 10.9%   
Share capital Rs m1,6940-   
"Free" reserves Rs m19,7040-   
Net worth Rs m21,3984,785,228 0.4%   
Long term debt Rs m21,685,052 0.0%   
Total assets Rs m39,1137,480,400 0.5%  
Interest coverage x1,091.0-6.6 -16,474.4%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.2 515.7%   
Return on assets %11.4-4.1 -278.1%  
Return on equity %20.8-7.8 -266.5%  
Return on capital %31.9-4.8 -659.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-6,5570-   
CASH FLOW
From Operations Rs m3,994414,491 1.0%  
From Investments Rs m-1,433227,709 -0.6%  
From Financial Activity Rs m-3,584-711,391 0.5%  
Net Cashflow Rs m-1,023-68,845 1.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.49 Rs / USD

Compare GSK PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare GSK PHARMA With: STERLING BIOTECH  NATCO PHARMA  SANOFI INDIA  PFIZER  UNICHEM LAB  



Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)

Oct 30, 2020 | Updated on Oct 30, 2020

For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

GSK PHARMA SHARE PRICE


May 14, 2021 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GSK PHARMA

GSK PHARMA 8-QTR ANALYSIS

COMPARE GSK PHARMA WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS